Literature DB >> 26464677

Reverse correlation of Jab1 and Smad4 in PANC-1 cells involved in the pathogenesis of pancreatic cancer.

Jun Li1, Zhuoyu Gu2, Siyuan Li2, Zhiwei Xiao2, Kan Sun1.   

Abstract

OBJECTIVE: Steps in the genetic basis of pancreatic cancer (PC) have been recently identified, however, Studies focusing on the relationship between Jab1 and Smad4 in PC are rarely reported. This study was performed to examine the expression patterns and association of Jab1 and Smad4 in PC cells for gaining a further understanding of PC pathogenesis.
METHODS: Human pancreatic cancer cell line PANC-1 cells were infected with retrovirus vector containing GFP, HA-Jab1, siGFP, and siJab1 respectively. The expression of Jab1 and Smad4 in PANC-1 cells was analyzed by Western blot and immunocytochemistry. Subsequently, the effect of overexpression of Jab1 on cell proliferation inhibition mediated by TGF-β was examined with MTT colorimetry.
RESULTS: The expression of Smad4 in PANC-1 cells was inhibited after the overexpression of Jab1. Inversely, the expression of Smad4 was increased after the down-regulation of Jab1 silenced by SiRNA. Smad4 expression in PANC-1 cells was negatively correlated with Jab1 expression. In addition, the cell proliferation inhibitory effect induced by TGF-β in PANC-1 cells was attenuated after the overexpression of Jab1.
CONCLUSIONS: The reverse correlation of Jab1 and Smad4 in PANC-1 cells may be involved in the Pathogenesis of PC. Jab1 can cause degradation of Smad4 via TGF-β signal pathway, consequently contributing to the proliferation of PC cells.

Entities:  

Keywords:  Jab1; Smad4; TGF-β; pancreatic cancer

Mesh:

Substances:

Year:  2015        PMID: 26464677      PMCID: PMC4583909     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  26 in total

1.  Smad4 protein stability is regulated by ubiquitin ligase SCF beta-TrCP1.

Authors:  Mei Wan; Yi Tang; Ewan M Tytler; Chongyuan Lu; Bingwen Jin; Selwyn M Vickers; Lei Yang; Xingming Shi; Xu Cao
Journal:  J Biol Chem       Date:  2004-02-26       Impact factor: 5.157

2.  Cancer statistics: current diagnosis and treatment of pancreatic cancer in Shanghai, China.

Authors:  Jiang Long; Guo-pei Luo; Zhi-wen Xiao; Zu-qiang Liu; Meng Guo; Liang Liu; Chen Liu; Jin Xu; Yu-tang Gao; Ying Zheng; Chunxiao Wu; Quan-xing Ni; Min Li; Xianjun Yu
Journal:  Cancer Lett       Date:  2014-01-21       Impact factor: 8.679

3.  Loss of Smad4 function in pancreatic tumors: C-terminal truncation leads to decreased stability.

Authors:  D Maurice; C E Pierreux; M Howell; R E Wilentz; M J Owen; C S Hill
Journal:  J Biol Chem       Date:  2001-09-11       Impact factor: 5.157

4.  Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1.

Authors:  K Tomoda; Y Kubota; J Kato
Journal:  Nature       Date:  1999-03-11       Impact factor: 49.962

Review 5.  Plant COP9 signalosome subunit 5, CSN5.

Authors:  Dan Jin; Bosheng Li; Xing-Wang Deng; Ning Wei
Journal:  Plant Sci       Date:  2014-04-08       Impact factor: 4.729

Review 6.  Interleukin-8 and human cancer biology.

Authors:  K Xie
Journal:  Cytokine Growth Factor Rev       Date:  2001-12       Impact factor: 7.638

7.  Annual report on status of cancer in China, 2010.

Authors:  Wanqing Chen; Rongshou Zheng; Siwei Zhang; Ping Zhao; Hongmei Zeng; Xiaonong Zou; Jie He
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

8.  JAB1 regulates unphosphorylated STAT3 DNA-binding activity through protein-protein interaction in human colon cancer cells.

Authors:  Arata Nishimoto; Naruji Kugimiya; Toru Hosoyama; Tadahiko Enoki; Tao-Sheng Li; Kimikazu Hamano
Journal:  Biochem Biophys Res Commun       Date:  2013-08-01       Impact factor: 3.575

Review 9.  Targeting Jab1/CSN5 in nasopharyngeal carcinoma.

Authors:  Yunbao Pan; Francois X Claret
Journal:  Cancer Lett       Date:  2012-08-04       Impact factor: 8.679

Review 10.  Molecular pathology of pancreatic cancer.

Authors:  Yuriko Saiki; Akira Horii
Journal:  Pathol Int       Date:  2014-01       Impact factor: 2.534

View more
  3 in total

Review 1.  The emerging roles of Jab1/CSN5 in cancer.

Authors:  Lin Wang; Jun-Nian Zheng; Dong-Sheng Pei
Journal:  Med Oncol       Date:  2016-07-13       Impact factor: 3.064

2.  Chemogenomic study of gemcitabine using Saccharomyces cerevisiae as model cell-molecular insights about chemoresistance.

Authors:  Lucas de Sousa Cavalcante; Tales A Costa-Silva; Tiago Antônio Souza; Susan Ienne; Gisele Monteiro
Journal:  Braz J Microbiol       Date:  2019-09-12       Impact factor: 2.476

Review 3.  Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer.

Authors:  Guohong Liu; Francois X Claret; Fuling Zhou; Yunbao Pan
Journal:  Front Pharmacol       Date:  2018-02-27       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.